This is not the most recent version of the article. View current version (8 APR 2015)

Intervention Protocol

Botulinum A toxin for focal hand dystonia

  1. David M Flaschner1,*,
  2. Nigel L Ashworth2,
  3. Patrick J Potter3

Editorial Group: Cochrane Movement Disorders Group

Published Online: 26 JAN 2004

DOI: 10.1002/14651858.CD004556


How to Cite

Flaschner DM, Ashworth NL, Potter PJ. Botulinum A toxin for focal hand dystonia (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD004556. DOI: 10.1002/14651858.CD004556.

Author Information

  1. 1

    University of Alberta, Physical Medicine and Rehabilitation, Edmonton, Alberta, Canada

  2. 2

    University of Alberta, Physical Medicine & Rehabilitation, Edmonton, Alberta, Canada

  3. 3

    University of Western Ontario, Physical Medicine and Rehabilitation, Not specified

*David M Flaschner, Physical Medicine and Rehabilitation, University of Alberta, Glenrose Rehabilitation Hospital, Room 1229, 10230 111 Avenue, Edmonton, Alberta, T5G 0B7, Canada. df2@ualberta.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 26 JAN 2004

SEARCH

This is not the most recent version of the article. View current version (08 APR 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This article will examine the safety and efficacy of botulinum A toxin for the treatment of focal hand dystonias of all etiologies.